Logotype for Research Solutions Inc

Research Solutions (RSSS) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Research Solutions Inc

Q2 2025 earnings summary

24 Dec, 2025

Executive summary

  • Total revenue for Q2 FY2025 was $11.9 million, up 15.5% year-over-year, driven by record organic platform deployments, customer expansion, and the Scite acquisition.

  • Platform revenue rose 47% to $4.6 million, now 39% of total revenue, with B2C and B2B segments both contributing to growth.

  • Annual recurring revenue (ARR) increased 23% to $19.1 million, with B2B ARR at $12.7 million and B2C ARR at $6.4 million.

  • Net loss was $2 million, or $0.07 per share, compared to a net loss of $54,000 in the prior year, mainly due to a $2.4 million provision for Scite earn-out.

  • Adjusted EBITDA improved to $963,000, up 202% year-over-year, reflecting improved operating performance excluding non-recurring items.

Financial highlights

  • Gross margin improved to 48.9%, up 540 basis points year-over-year, driven by a shift to higher-margin platform business.

  • Transaction revenue was $7.3 million, up 1.7% year-over-year, with modest growth mainly from the academic segment.

  • Operating expenses increased 16.8% year-over-year, mainly from higher sales, marketing, and technology costs associated with the Scite acquisition.

  • Cash and cash equivalents were $7.7 million at quarter end, with strong cash flow from operations of $1 million in the quarter.

  • For the six months ended December 31, 2024, total revenue was $24.0 million, up 17.6% year-over-year, with a net loss of $1.3 million.

Outlook and guidance

  • Expect continued strong performance in Q3 and Q4, with Q3 and Q4 typically being the strongest for profitability and cash flow.

  • Management expects continued growth from expanded platform deployments, customer base expansion, and integration of Scite and Resolute AI.

  • Anticipate increased sales and marketing investment in the next quarters, with CAC and CAC to LTV temporarily impacted but expected to normalize as bookings accelerate.

  • No material shift expected in SG&A expenses from Q2 levels.

  • No material changes to risk factors or forward-looking statements since the last annual report.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more